New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
KARDIGAN INC (KARD) vs Nektar Therapeutics (NKTR)
- KARDIGAN INC KARD 11.54 −7.83%
- Nektar Therapeutics NKTR 30.20 −7.19%
KARDIGAN INC and Nektar Therapeutics are both Biotechnology companies. KARDIGAN INC and Nektar Therapeutics are of similar size ($1.2B and $1.1B). Across the 9 metrics below, Nektar Therapeutics leads on 6 and KARDIGAN INC on 3.
Valuation
Profitability
| Metric | KARD | NKTR | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 70.18% |
| Operating margin | — | (319.75%) | 0.00% |
| Net margin | — | (339.67%) | 0.00% |
| Free cash flow margin | — | (493.41%) | 0.00% |
| Return on equity | (117.38%) | (37.92%) | (51.58%) |
| Return on assets | (80.59%) | (26.48%) | (45.91%) |
| Return on invested capital | (187.24%) | (44.31%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack